Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 108 of the 113 references it cites were found in a registry or an index; 68 of the 122 sources its claims cite were checked for support.

The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features

Open access
Iverson, Grant L., Keene, C. Dirk, Perry, George, Castellani, Rudolph J. · 2017 · Journal of Alzheimer's Disease

Abstract

Critical review examining the necessity of separating CTE neuropathology from clinical features, noting that CTE might not be pathologically or clinically progressive in a substantial percentage of people.

Overview

CoChat Summary

TL;DR

The paper argues that CTE neuropathology should be separated from the broad clinical features attributed to it, because current evidence does not establish that CTE is inexorably progressive or that its pathology predicts specific symptoms. It calls for more research to determine whether the neuropathology ascribed to neurotrauma is static, progressive, or both.

Key findings

  • The 2015 NIH consensus panel defined a single “pathognomonic” CTE criterion—abnormal p-tau in neurons, astrocytes, and cell processes around small vessels in an irregular pattern at the depths of cortical sulci—and listed supportive criteria including superficial-layer pretangles/NFTs, CA2/CA4 hippocampal involvement, subcortical p-tau aggregates, thorny astrocytes at the glial limitans, and grain-like/dot-like structures.
  • Postmortem studies report CTE-like pathology in people with other conditions or without known sport exposure: Ling et al. screened 268 cases and found pathology consistent with CTE in 32 (11.9%), all Stage I or II, with mean age at death 81.0 years; Koga et al. found CTE pathology in 8 of 139 multiple system atrophy cases (6%); Noy et al. found Stage I/II CTE pathology in 4.5% of 111 routine neuropathology brains, plus an additional 34 cases (30.6%) with less than Stage I pathology, totaling 35.1%.
  • In Bieniek et al., 21 of 66 former athletes (31.8%) had tau pathology suggestive of CTE, all with a separate neurodegenerative disease; 14 of 21 (66.7%) had Stage I or II pathology, and there were no differences between former athletes with versus without CTE pathology in disease onset, disease duration, or age at death.
  • Historical evidence from Roberts’ study of boxers—250 selected, 224 examined—found 17% with the syndrome (11% mild, 6% severe); most had a static course, with anecdotal improvement after retirement and only a small subgroup appearing progressive beyond aging.

Methods

  • Critical review, not a primary study; it places recent CTE research in historical context and synthesizes neuropathology consensus criteria, postmortem series, and proposed clinical criteria.
  • Describes the NIH consensus panel: seven neuropathologists blindly examined 10 advanced CTE cases (2 Stage III, 8 Stage IV; former professional athletes ages 60–85) and 15 cases with primary tau-related neurodegenerative diseases.
  • Reviews selected postmortem and clinical studies (e.g., Roberts, Ling, Bieniek, Koga, Noy) and historical literature; no new data collection or meta-analysis is described.

Limitations

  • Stated: the consensus panel acknowledged the limitation of using only “moderate to late stage” CTE to develop criteria; there are no prospective, longitudinal, or epidemiological studies supporting the theory that CTE pathology is progressive; there are no agreed upon or validated clinical criteria; and it is unknown whether symptoms can be predicted by specific combinations of neuropathologies, thresholds for accumulation, or regional distributions.
  • Stated: a correlation between CTE pathology and depression has not been established, and several reviews focused specifically on suicide concluded there is minimal or no scientific evidence to support suicide as a clinical feature of CTE.
  • Evident from the text: as a critical review, its conclusions depend on existing literature and postmortem series, many of which predate the 2015 consensus criteria; the authors note that some past cases may have misclassified PART or ARTAG pathology as CTE, so prevalence estimates might differ under current criteria.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3233/jad-170654

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

46 Valid · 7 Not valid · 14 Not checked · 31 Own results and interpretations

45 more claims · 15 with their cited sources checked

Create a free account to see all 98 claims and to verify the 2 references still open.

See all claims — free account
  • It may state two separate claims as one. 33
  • Probably not a substantial claim. 21

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 113 references

Research works printed but not linked: 4

  1. Roberts, 1969, Brain damage in boxers: A study of prevalence of traumatic encephalopathy among ex-professional boxers
  2. Millspaugh, 1937, Dementia pugilistica, U S Nav Med Bull, 35, 297
  3. Critchley, 1949, Punch-drunk syndromes: The chronic traumatic encephalopathy of boxers. Hommage a Clovis Vincent (ed)
  4. Vanharanta, 1989, [Back pain], Duodecim, 105, 105

Cited by

See all 72

Metadata

Authors
Iverson, G. L., Keene, C. D., Perry, G., & Castellani, R. J.
Affiliations
  • Harvard University (US)
  • University of Washington (US)
  • The University of Texas at San Antonio (US)
  • Western Michigan University (US)
Corresponding author
Iverson, Grant L.
Venue
Journal of Alzheimer's Disease
Published
2017-11-28
Volume
61
Issue
1
Pages
17-28
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2765730264
Cited by
72
References
113
Citations by year
2026: 4 · 2025: 14 · 2024: 6 · 2023: 5 · 2022: 4 · 2021: 8 · 2020: 8 · 2019: 19 · 2018: 4
FWCI
5.15
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (submittedVersion, cc-by-nc)
  • PubMed Central (submittedVersion, cc-by-nc)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Keywords
chronic traumatic encephalopathy, neuropathology
MeSH terms
Neuropathology, Chronic Traumatic Encephalopathy, Cognition Disorders, Humans, Tremor, Disease Progression, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features. https://app.cochat.ai/papers/10.3233/jad-170654
The paper
Iverson, G. L., Keene, C. D., Perry, G., & Castellani, R. J. (2017). The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-170654

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.